Closing the healthcare gap at the annual Pink Ribbon Girls’ “Ignite The Fight” Gala
CEO Cheryl Contee shares her personal connection to the fight against cancer in her touching keynote address.
At The Impact Seat Foundation, we’re passionate about funding equitable access to healthcare for all women, especially for women of color. When Black women are 42% more likely to die from breast cancer than other women”, and 3 times more likely to die from pregnancy complications, we must collectively understand that it is our fiduciary responsibility to bridge the equity gap.
This year we were honored to partner with Pink Ribbon Girls, a foundation dedicated to supporting women through their fight with breast and gynecological cancer through services and peer support.
The Impact Seat Foundation’s CEO, Cheryl Contee, was invited to deliver a special keynote address at Pink Ribbon Girls’ annual Ignite The Fight Gala. Joined by her son Colm, Cheryl honored the legacy of her late mother, who lost her battle with cancer this year, and touched on the amazing work PRG has accomplished thus far in their mission to create an equitable world for women.
Founded in 2002, Pink Ribbon Girls started as a grassroots organization of just a few people dedicated to bringing warm meals to cancer patients. Since then, it has not only expanded its services, but earned countless partnerships to further these services and expanded to multiple states, encompassing the Dayton region of Ohio, the St. Louis region of Missouri, and the San Francisco Bay Area.
Pink Ribbon Girls’ referrals continue to increase and the need for support has grown; 35% of Pink Ribbon Girls’ clients are food-insecure and 30% are ride-insecure. Last year, they served over 36,000 meals nationwide.
We are honored to support this powerful organization on their mission. This year’s Ignite The Fight Gala raised over $350,000 to continue to fund Pink Ribbons Girls’ programs for patients. We share in the hope of the organization’s mission that fewer women will suffer through these difficult diseases and critical gaps in care and treatment will one day close.
